These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20815249)

  • 1. [Progress in application of targeting viral vector regulated by microRNA in gene therapy: a review].
    Zhang G; Wang Q; Zhang J; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):707-14. PubMed ID: 20815249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid vector designs to control the delivery, fate and expression of transgenes.
    Lam PY; Breakefield XO
    J Gene Med; 2000; 2(6):395-408. PubMed ID: 11199260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroManipulating viral-based therapeutics.
    Tenoever B
    Discov Med; 2009 Aug; 8(41):51-4. PubMed ID: 19788867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of viral vectors for neurological gene therapies.
    Maguire-Zeiss KA; Federoff HJ
    Curr Opin Mol Ther; 2004 Oct; 6(5):473-81. PubMed ID: 15537048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE; Nettelbeck DM
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and application of inducible artificial microRNA expression vector targeting eIF3g gene].
    Chu LS; Han N; Song XY; Cao J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):135-8. PubMed ID: 21315039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral vector-mediated RNA interference.
    Couto LB; High KA
    Curr Opin Pharmacol; 2010 Oct; 10(5):534-42. PubMed ID: 20620113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
    Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
    Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camels and zebrafish, viruses and cancer: a microRNA update.
    Berezikov E; Plasterk RH
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R183-90. PubMed ID: 16244316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
    Werner M; Kraunus J; Baum C; Brocker T
    Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral vectors for gene therapy.
    Robbins PD; Ghivizzani SC
    Pharmacol Ther; 1998 Oct; 80(1):35-47. PubMed ID: 9804053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing liver-specific microRNA-122 to modulate replication of dengue virus replicon.
    Lee TC; Lin YL; Liao JT; Su CM; Lin CC; Lin WP; Liao CL
    Biochem Biophys Res Commun; 2010 Jun; 396(3):596-601. PubMed ID: 20412785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances with the use of bio-inspired vectors towards creation of artificial viruses.
    McCarthy HO; Wang Y; Mangipudi SS; Hatefi A
    Expert Opin Drug Deliv; 2010 Apr; 7(4):497-512. PubMed ID: 20151849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
    Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
    Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective inhibition of replication of infectious bursal disease virus by miRNAs delivered by vectors and targeting the VP2 gene.
    Wang Y; Sun H; Shen P; Zhang X; Xia X; Xia B
    J Virol Methods; 2010 May; 165(2):127-32. PubMed ID: 19189848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.